Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Sustained Release Injectables market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.9% during the forecast period.
This report presents the market size and development trends by detailing the Sustained Release Injectables market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Sustained Release Injectables market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Sustained Release Injectables industry and will help you to build a panoramic view of the industrial development.
Sustained Release Injectables Market, By Type:
Naltrexone
Exenatide
Estradiol
Other
Sustained Release Injectables Market, By Application:
Diabetes
Leukemia
Acromegaly
Other
Some of the leading players are as follows:
Ascendis Pharma
Avadel
Sanofi
Taiwan Liposome Company
Novartis
Camurus
Critical Pharmaceuticals
Eli Lilly
Roche
Amylin
AstraZeneca
Alkermes
Biomarin
Aurobindo
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Sustained Release Injectables Market: Technology Type Analysis
-
4.1 Sustained Release Injectables Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Sustained Release Injectables Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Naltrexone
4.3.2 Exenatide
4.3.3 Estradiol
4.3.4 Other
5 Sustained Release Injectables Market: Product Analysis
-
5.1 Sustained Release Injectables Product Market Share Analysis, 2018 & 2026
-
5.2 Sustained Release Injectables Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Sustained Release Injectables Market: Application Analysis
-
6.1 Sustained Release Injectables Application Market Share Analysis, 2018 & 2026
-
6.2 Sustained Release Injectables Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Diabetes
6.3.2 Leukemia
6.3.3 Acromegaly
6.3.4 Other
7 Sustained Release Injectables Market: Regional Analysis
-
7.1 Sustained Release Injectables Regional Market Share Analysis, 2018 & 2026
-
7.2 Sustained Release Injectables Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Ascendis Pharma
9.1.1 Ascendis Pharma Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Avadel
9.2.1 Avadel Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Sanofi
9.3.1 Sanofi Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Taiwan Liposome Company
9.4.1 Taiwan Liposome Company Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Novartis
9.5.1 Novartis Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Camurus
9.6.1 Camurus Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Critical Pharmaceuticals
9.7.1 Critical Pharmaceuticals Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Eli Lilly
9.8.1 Eli Lilly Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Roche
9.9.1 Roche Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Amylin
9.10.1 Amylin Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 AstraZeneca
9.11.1 AstraZeneca Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Alkermes
9.12.1 Alkermes Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Biomarin
9.13.1 Biomarin Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Aurobindo
9.14.1 Aurobindo Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
The List of Tables and Figures (Totals 79 Figures and 146 Tables)
Figure Naltrexone Sustained Release Injectables market, 2015 - 2026 (USD Million)
Figure Exenatide Sustained Release Injectables market, 2015 - 2026 (USD Million)
Figure Estradiol Sustained Release Injectables market, 2015 - 2026 (USD Million)
Figure Other Sustained Release Injectables market, 2015 - 2026 (USD Million)
Figure Diabetes market, 2015 - 2026 (USD Million)
Figure Leukemia market, 2015 - 2026 (USD Million)
Figure Acromegaly market, 2015 - 2026 (USD Million)
Figure Other market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Sustained Release Injectables market, by country, 2015 - 2026 (USD Million)
-
Table North America Sustained Release Injectables market, by type, 2015 - 2026 (USD Million)
-
Table North America Sustained Release Injectables market, by product, 2015 - 2026 (USD Million)
-
Table North America Sustained Release Injectables market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Sustained Release Injectables market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Sustained Release Injectables market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Sustained Release Injectables market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Sustained Release Injectables market, by type, 2015 - 2026 (USD Million)
-
Table Canada Sustained Release Injectables market, by product, 2015 - 2026 (USD Million)
-
Table Canada Sustained Release Injectables market, by application, 2015 - 2026 (USD Million)
-
Table Europe Sustained Release Injectables market, by country, 2015 - 2026 (USD Million)
-
Table Europe Sustained Release Injectables market, by type, 2015 - 2026 (USD Million)
-
Table Europe Sustained Release Injectables market, by product, 2015 - 2026 (USD Million)
-
Table Europe Sustained Release Injectables market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Sustained Release Injectables market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Sustained Release Injectables market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Sustained Release Injectables market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Sustained Release Injectables market, by type, 2015 - 2026 (USD Million)
-
Table Germany Sustained Release Injectables market, by product, 2015 - 2026 (USD Million)
-
Table Germany Sustained Release Injectables market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Sustained Release Injectables market, by type, 2015 - 2026 (USD Million)
-
Table France Sustained Release Injectables market, by product, 2015 - 2026 (USD Million)
-
Table France Sustained Release Injectables market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Sustained Release Injectables market, by type, 2015 - 2026 (USD Million)
-
Table Italy Sustained Release Injectables market, by product, 2015 - 2026 (USD Million)
-
Table Italy Sustained Release Injectables market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Sustained Release Injectables market, by type, 2015 - 2026 (USD Million)
-
Table Spain Sustained Release Injectables market, by product, 2015 - 2026 (USD Million)
-
Table Spain Sustained Release Injectables market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Sustained Release Injectables market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Sustained Release Injectables market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Sustained Release Injectables market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Sustained Release Injectables market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Sustained Release Injectables market, by type, 2015 - 2026 (USD Million)
-
Table China Sustained Release Injectables market, by product, 2015 - 2026 (USD Million)
-
Table China Sustained Release Injectables market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Sustained Release Injectables market, by type, 2015 - 2026 (USD Million)
-
Table Japan Sustained Release Injectables market, by product, 2015 - 2026 (USD Million)
-
Table Japan Sustained Release Injectables market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Sustained Release Injectables market, by type, 2015 - 2026 (USD Million)
-
Table India Sustained Release Injectables market, by product, 2015 - 2026 (USD Million)
-
Table India Sustained Release Injectables market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Sustained Release Injectables market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Sustained Release Injectables market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Sustained Release Injectables market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Sustained Release Injectables market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Sustained Release Injectables market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Sustained Release Injectables market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Sustained Release Injectables market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Sustained Release Injectables market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Sustained Release Injectables market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Sustained Release Injectables market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Sustained Release Injectables market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Sustained Release Injectables market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Sustained Release Injectables market, by application, 2015 - 2026 (USD Million)
-
Table MEA Sustained Release Injectables market, by country, 2015 - 2026 (USD Million)
-
Table MEA Sustained Release Injectables market, by type, 2015 - 2026 (USD Million)
-
Table MEA Sustained Release Injectables market, by product, 2015 - 2026 (USD Million)
-
Table MEA Sustained Release Injectables market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Sustained Release Injectables market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Sustained Release Injectables market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Sustained Release Injectables market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Sustained Release Injectables market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Sustained Release Injectables market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Sustained Release Injectables market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Ascendis Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Avadel Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Taiwan Liposome Company Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Camurus Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Critical Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Eli Lilly Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Roche Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Amylin Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Alkermes Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Biomarin Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Aurobindo Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
